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Aims and objective: Despite effective treatment of pulmonary tuberculosis (TB) patients,
destruction of lung parenchyma may lead to complications including repeated infections.
These infections are often misdiagnosed or wrongly identified as TB recurrence, and hence
are not treated effectively. The frequency and severity of these infections vary with the
extent of damage, and are much more prominent in patients with post-TB bronchiectasis
and fibrocavitary diseases. This presentation will focus on the epidemiology, treatment,
and management of post-TB infections and challenges, and the impact of these infections
on public health in high-TB-burden countries.
Methods: Published literature and review articles were evaluated to address this objective.
Results: Apart from conventional agents of pneumonia, patients with post-TB bronchiecta-
sis and post-TB fibrocavitary diseases are prone to develop chronic pulmonary aspergillosis
and nontuberculous mycobacterial infections. A high burden of chronic pulmonary
aspergillosis has been reported in TB-endemic countries. Similarly, prior TB increases the
risk of acquiring nontuberculous mycobacterial infections. Diagnosis and management
of chronic pulmonary aspergillosis and nontuberculous mycobacterial infections require
expertise and high-level care.
Conclusion: Limited diagnostic and therapeutic capacities compounded by nonavailability
of essential antimicrobials in most high-TB-burden countries pose great challenges to
physicians involved in the management of these infections. These infections affect the
overall outcome and lead to high cost for public health systems.Conflict of intrest
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